Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05197257 · ClinicalTrials.gov registry record · Phase 3
68Ga-PSMA-11 PET in Patients With Prostate Cancer
A Phase 3 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 3
- Development phase
- 39
- Enrollment target
NCT05197257 is a Phase 3 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 39 participants.
The verdict
NCT05197257, a Phase 3 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 39 participants
- Enrollment target
Study Summary
Patients will receive a single dose of 68Ga-PSMA-11 and undergo a PET/CT or PET/MRI imaging study.
Interventions
- DRUG Ga-PSMA-11
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2021-09-29 |
| Est. Completion | 2022-04-14 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05197257
The ClinicalTrials.gov registry entry for NCT05197257 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ga-PSMA-11 is the first listed.
NCT05197257 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05197257 about?
NCT05197257 is a clinical study titled "68Ga-PSMA-11 PET in Patients With Prostate Cancer". Patients will receive a single dose of 68Ga-PSMA-11 and undergo a PET/CT or PET/MRI imaging study.
What is the current status of trial NCT05197257?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 39 participants. The study started on 2021-09-29. Estimated completion is 2022-04-14.
What interventions are being tested in trial NCT05197257?
The interventions under investigation include: Ga-PSMA-11 (DRUG).
Who is sponsoring clinical trial NCT05197257?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.